about
Assessing safety culture in pharmacies: the psychometric validation of the Safety Attitudes Questionnaire (SAQ) in a national sample of community pharmacies in SwedenPharmacist-patient communication in Swedish community pharmacies.Exploring community pharmacists' experiences of surveying patients for drug utilization research purposes.Stakeholders' expectations and perceived effects of the pharmacy ownership liberalization reform in Sweden: a qualitative interview studyReregulation of the Swedish pharmacy sector-A qualitative content analysis of the political rationale.Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.Deregulation of nonprescription medicines in Sweden-a look at the control system.Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions.Social Pharmacy Research in Copenhagen-Maintaining a Broad Approach.Introducing Pharmaceutical Care to Primary Care in Iceland-An Action Research Study.The Raison D'être for the Community Pharmacy and the Community Pharmacist in Sweden: A Qualitative Interview Study.Developing and sustaining human resources in the health supply chain in Ethiopia: barriers and enablers.Customers' perceptions of and satisfaction with medicine retail outlet services in Addis Ababa, Ethiopia: a cross-sectional study.Sildenafil citrate use in Addis Ababa: characteristics of users and pharmacists' dispensing practices.The influence of generic substitution on the content of patient-pharmacist communication in Swedish community pharmacies.'Because of the circumstances, we cannot develop our role': Norwegian community pharmacists' perceived responsibility in role development.How does media coverage effect the consumption of antidepressants? A study of the media coverage of antidepressants in Danish online newspapers 2010-2011.Developing ethical competence in health care organizations.Implementation of a pharmaceutical care service: prescriptionists', pharmacists' and doctors' views.Living with conflicts-ethical dilemmas and moral distress in the health care system.Receiving a pharmaceutical care service compared to receiving standard pharmacy service in Sweden--How do patients differ with regard to perceptions of medicine use and the pharmacy encounter?Counselling behaviour and content in a pharmaceutical care service in Swedish community pharmacies.Legal cognitive requirements impact on pharmacy practice and patient outcomes.Pharmacy care perspectives on problems with HIV antiretroviral therapy in Sweden.Managing Complexity: Exploring Decision Making on Medication by Young Adults with ADHD.Selection bias in pharmacy-based patient surveys.Human resource development in supply chain management- what do the UN agencies say?Ethical review boards are poor advocates for patient perspectivesPharmacists’ experiences and attitudes regarding generic drugs and generic substitution: two sides of the coinExperiences of a nationwide web-based system: reporting dispensing errors in Swedish pharmaciesReducing dispensing errors in Swedish pharmacies: the impact of a barrier in the computer systemTrends in Pharmacy Practice Communication ResearchSwedish patients' trust in the bioequivalence of interchangeable generics. What factors are important for low trust?Culture of antibiotic use in Kosovo - an interview study with patients and health professionalsCompetence, competition and collaboration: Perceived challenges among Swedish community pharmacists engaging in pharmaceutical services provision and researchViews on the role of community pharmacy in local communities: a case study of stakeholders' attitudesPatients', Pharmacy Staff Members', and Pharmacy Researchers' Perceptions of Central Elements in Prescription Encounters at the Pharmacy CounterA Qualitative Study on Danish Student Pharmacists' Attitudes Towards and Experience of Communication Skills TrainingPerceptions, preferences and acceptability of patient designed 3D printed medicine by polypharmacy patients: a pilot study
P50
Q33551517-E0FA6B88-E632-4F37-B0DB-BC388CDE6D4DQ34671082-A37A7124-3F01-48FD-8F0F-49DFE7264A9EQ35570964-0AA6076A-6CD6-4C3F-85BC-0D3CFCBE7AB5Q36103188-CFAD83D9-D80B-4A24-9611-C0C34DD1475CQ39196844-EB4BB7FF-40A9-4018-B6FB-DE28B7232657Q39963170-E1A4B731-910D-41AD-BD01-65FB3668A0EFQ40020606-F9447135-DB48-4BF3-AC0E-F605E6F97207Q41204304-08A2C0AD-E088-4E89-B40A-C3A93939387FQ41935380-CBF348D8-E0C6-49CC-97DC-BECE5C0BB6D8Q42131274-548F1ECB-77A9-43D3-875D-D022EF7ED255Q42289348-61E40B0F-E1BD-4237-9D17-893930E1D0F9Q46153593-B6496C29-2263-47CE-8089-B0297E61A028Q46444332-29A7D698-1179-41DF-8DEC-2B44B035A957Q47602883-8C99E580-95CB-4BE1-9493-219C5B784354Q47713219-A9648D0D-EC31-4968-97A0-E605794631F2Q47714358-B158143D-4AC1-49A4-BAEE-89376667B1C9Q47740077-20C726ED-3C02-4316-88DB-45B576280F71Q48381992-46C39820-EA54-4B62-82C9-7C33E5143D72Q48388451-ABD0C460-E690-4CBB-A9F7-A7C9E4804269Q48563786-06C15DA2-91C9-4D7F-ADD1-4EE2482FD4EAQ50670187-673D5A04-6A5E-4C35-BBF9-E3EF0F2D04CCQ50784811-6349E0F1-13EF-41A3-8E29-A28D064A18B9Q50956292-D2EE640A-0094-473A-BF3F-30F8937687C5Q51992918-00EAC43A-5055-40D8-8FF7-62146AA33DDAQ52315889-6B0E7478-A7E1-422B-94E5-BAAA433E6B48Q53126420-ED46D8D2-19D8-46FE-987C-BB077253A8F8Q57660120-95EAAD9E-3315-45F6-A584-8DFB4A32A974Q58883861-43CFD99C-4A43-4BCD-A75B-B01285577B72Q58883870-1DB657DD-38C5-4BF1-A383-ACF5A6B92C3AQ58883873-44AA4094-D85B-457C-915D-886D54DF915CQ58883875-669C7D94-8492-491D-AD72-F5CCCF6B1E93Q60916724-51C954EA-22CA-46A5-87CF-B092F1DF592CQ60955830-51F75A8A-091E-40B1-837A-6D160FE71744Q90582385-D0FE7E99-0DE8-493E-89C6-A5E4D646841EQ91304251-808D1AF1-A796-4F4F-9169-2A2F8DE41FB0Q91640765-314E0375-A0CA-403A-B73D-DB8DE5D8E7AFQ91657742-7068A427-5B7E-46FB-BA02-DEAEA64D2206Q92219192-3441F827-11A1-4CC8-AACC-3D760AB7D0D8Q92835191-7BCBA009-8CA6-4C65-B06E-6107D046CAE2
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sofia K Sporrong
@nl
Sofia K Sporrong
@sl
Sofia K. Sporrong
@en
Sofia K. Sporrong
@es
type
label
Sofia K Sporrong
@nl
Sofia K Sporrong
@sl
Sofia K. Sporrong
@en
Sofia K. Sporrong
@es
prefLabel
Sofia K Sporrong
@nl
Sofia K Sporrong
@sl
Sofia K. Sporrong
@en
Sofia K. Sporrong
@es
P106
P1153
18134038400
P21
P31
P496
0000-0001-5848-8625